Comments
Loading...
Lucid Diagnostics (LUCD) Forecast
NewsEarningsLucid Diagnostics (LUCD) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestLucid Diagnostics (NASDAQ:LUCD) Stock Quotes, Forecast and News Summary
Lucid Diagnostics Stock (NASDAQ: LUCD) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Lucid Diagnostics (LUCD) stock?
You can purchase shares of Lucid Diagnostics (NASDAQ:LUCD) through any online brokerage.
Who are Lucid Diagnostics (LUCD) competitors?
Other companies in Lucid Diagnostics’s space includes: LENSAR (NASDAQ:LNSR), Pro-Dex (NASDAQ:PDEX), Nexalin Technology (NASDAQ:NXL), Modular Medical (NASDAQ:MODD) and Sight Sciences (NASDAQ:SGHT).
What is the forecast, or price target, for Lucid Diagnostics (LUCD) stock?
Lucid Diagnostics has a consensus price target of $3.67.
What is the current price for Lucid Diagnostics (LUCD)?
The stock price for Lucid Diagnostics (NASDAQ: LUCD) is $1.3196 last updated February 11, 2025 at 2:07 PM EST.
Does Lucid Diagnostics (LUCD) pay a dividend?
There are no upcoming dividends for Lucid Diagnostics.
When is Lucid Diagnostics (NASDAQ:LUCD) reporting earnings?
Lucid Diagnostics’s Q4 earnings are confirmed for Monday, March 24, 2025.
Is Lucid Diagnostics (LUCD) going to split?
There is no upcoming split for Lucid Diagnostics.
What sector and industry does Lucid Diagnostics (LUCD) operate in?
Lucid Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.